| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Streptococci (serogroup G) |
0.03 |
0.03 |
0.03 － 0.03 |
Amoxicillin-clavulanic acid (Augmentin)  |
102 |
| Streptococci (serogroup G) |
0.03 |
0.06 |
0.015 － 0.06 |
Daptomycin + 50 μg/ml Ca++ |
67 |
| Streptococci (serogroup G) |
0.03 |
0.06 |
0.015 － 0.25 |
Daptomycin + 75 μg/ml Ca++ |
67 |
| Streptococci (serogroup G) |
0.06 |
0.12 |
0.03 － 0.25 |
Zosyn |
102 |
| Streptococci (serogroup G) |
0.06 |
0.12 |
? － ? |
Clinafloxacin (PD 127391) |
307 |
| Streptococci (serogroup G) |
0.06 |
0.25 |
0.03 － 0.25 |
Daptomycin + 25 μg/ml Ca++ |
67 |
| Streptococci (serogroup G) |
0.06 |
0.25 |
0.06 － 0.5 |
Teicoplanin (Targocid) |
67 |
| Streptococci (serogroup G) |
0.12 |
0.12 |
0.06 － 0.12 |
Garenoxacin (T-3811, BMS-284756) |
102 |
| Streptococci (serogroup G) |
0.25 |
0.25 |
0.12 － 0.25 |
Moxifloxacin (BAY 12-8039, Avelox) |
102 |
| Streptococci (serogroup G) |
0.25 |
0.25 |
0.125 － 0.25 |
Quinupristin/Dalfopristin (Synercid) |
246 |
| Streptococci (serogroup G) |
0.25 |
0.5 |
0.25 － 0.5 |
Gatifloxacin (Tequin) |
102 |
| Streptococci (serogroup G) |
0.3 |
0.3 |
0.25 － 0.5 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
| Streptococci (serogroup G) |
0.3 |
0.5 |
0.12 － 0.5 |
Vancomycin (Vancocyn, Lyphocin) |
246 |
| Streptococci (serogroup G) |
0.5 |
1 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
307 |
| Streptococci (serogroup G) |
0.5 |
2 |
0.2 － 2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
102 |
| Streptococci (serogroup G) |
2 |
2 |
0.12 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
246 |
| Streptococci (serogroup G) |
- |
2 |
0.12 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
726 |
| Streptococci (serogroup G) |
- |
- |
0.015 － 0.06 |
Daptomycin (Cubicin) |
1261 |
| Streptococci (serogroup G) |
- |
- |
0.25 － 0.5 |
Vancomycin (Vancocyn, Lyphocin) |
1261 |
| Streptococci (Viridans group + erythromycin-resistant) |
- |
0.03 |
≤0.002 － 0.06 |
Dalbavancin |
1112 |
| Streptococci (Viridans group + erythromycin-resistant) |
- |
0.03 |
? － ? |
Dalbavancin |
1112 |
| Streptococci (Viridans group + erythromycin-resistant) |
- |
0.12 |
? － ? |
Teicoplanin (Targocid) |
1112 |
| Streptococci (Viridans group + erythromycin-resistant) |
- |
1 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1112 |
| Streptococci (Viridans group + erythromycin-resistant) |
- |
1 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
1112 |
| Streptococci (Viridans group + erythromycin-resistant) |
- |
1 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1112 |
| Streptococci (Viridans group + erythromycin-susceptible) |
- |
0.03 |
≤0.002 － 0.03 |
Dalbavancin |
1112 |
| Streptococci (Viridans group + erythromycin-susceptible) |
- |
0.03 |
? － ? |
Dalbavancin |
1112 |
| Streptococci (Viridans group + erythromycin-susceptible) |
- |
0.06 |
? － ? |
Teicoplanin (Targocid) |
1112 |